The Board of Directors of Roivant Sciences Ltd. has authorized a buyback plan on April 2, 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.58 USD | -2.80% | +1.44% | -6.14% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.14% | 8.04B | |
+43.76% | 749B | |
+39.42% | 605B | |
-6.55% | 351B | |
+19.54% | 328B | |
+8.02% | 292B | |
+11.92% | 216B | |
-2.62% | 214B | |
+1.62% | 167B | |
+7.21% | 165B |
- Stock Market
- Equities
- ROIV Stock
- News Roivant Sciences Ltd.
- Roivant Sciences Ltd. authorizes a Buyback Plan.